American Healthcare REIT (AHR) has come into focus after completing a follow on equity offering of 13,250,000 common shares, raising about $712.2 million to help fund senior housing acquisitions and other uses.

Alongside the follow on offering, American Healthcare REIT has seen its share price move to $55.47, with a 90 day share price return of 7.77% and a year to date share price return of 17.42% that sits against a 1 year total shareholder return of 40.34%. This suggests momentum has been building around recent earnings guidance and capital plans.

If you are assessing how income focused real estate like senior housing stacks up against more growth oriented themes, it can be useful to also look at healthcare related AI opportunities through the 43 healthcare AI stocks.

After a strong run on fresh guidance and the $712.2 million equity raise, the question now is how much of American Healthcare REIT’s story is already reflected in the share price and how much potential upside remains in the valuation work ahead.

Most Popular Narrative: 7.7% Undervalued

The most followed narrative for American Healthcare REIT pegs fair value around $60.07 per share compared with the last close at $55.47. That gap rests on a detailed set of growth and profitability assumptions that go well beyond the recent equity raise headlines.

The combination of a rapidly growing 80+ demographic and a multi-year period of low new supply in senior housing and skilled nursing is expected to drive a persistent supply-demand imbalance, fueling both occupancy gains and rent growth across American Healthcare REIT's portfolio. This dynamic should underpin above-trend revenue and net operating income growth over the next decade.

Want to see what sits behind that growth story? The narrative leans on faster revenue expansion, thicker margins and a richer future earnings multiple. The specific mix of those three levers is what really drives that $60.07 fair value call.

Result: Fair Value of $60.07 (UNDERVALUED)

However, you still need to watch for a slowdown as senior housing occupancy levels stabilise, and for any pressure on government reimbursement that could squeeze American Healthcare REIT’s margins.

Another View On American Healthcare REIT’s Valuation

That 7.7% implied undervaluation is only one angle. On simple earnings multiples, American Healthcare REIT trades on a P/E of 99.9x, compared with a fair ratio of 50.8x and a Global Health Care REITs average of 17.4x. That is a wide gap that points to material valuation risk if expectations shift.

When one method flags undervaluation and another shows a rich P/E, which signal do you put more weight on for your own process See what the numbers say about this price — find out in our valuation breakdown..

Next Steps

Given the mix of optimism and concern around American Healthcare REIT, it makes sense to move quickly, test the numbers yourself, and weigh both sides of the story with the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond American Healthcare REIT?

If you are serious about building a stronger portfolio, do not stop at American Healthcare REIT. Use curated screeners to quickly spot fresh opportunities before they move.

• Target potential mispricings by scanning for companies that combine quality fundamentals with attractive valuations through the 51 high quality undervalued stocks.
• Strengthen your income stream by focusing on businesses with higher yields and resilient payouts using the 9 dividend fortresses.
• Reduce portfolio stress by concentrating on companies with healthier balance sheets and steadier fundamentals via the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.